Compartilhar
Informação da revista
Vol. 93. Núm. 6.
Páginas 902-904 (1 novembro 2018)
Compartilhar
Compartilhar
Baixar PDF
Mais opções do artigo
Vol. 93. Núm. 6.
Páginas 902-904 (1 novembro 2018)
Open Access
Paracoccidioidomycosis manifested by sarcoidosis-like cutaneous lesions and caused by Paracoccidioides brasiliensis sensu stricto (S1a)*
Visitas
4220
Sílvio Alencar Marques1, Marilia Formentini Scotton Jorge2, Marluce Francisca Hrycyk3, Sandra de Moraes Gimenes Bosco4
1 Department of Dermatology and Radiotherapy, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista, Botucatu (SP), Brazil
2 Dermatology Service, Hospital das Clínicas, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista, Botucatu (SP), Brazil
3 Laboratory of Microbiology and Immunology, Faculdade de Ciências Biológicas e Agrárias, Universidade do Estado de Mato Grosso, Alta Floresta (MT), Brazil
4 Laboratory of Medical Mycology, Departamento de Microbiologia e Imunologia, Instituto de Biociências de Botucatu, Universidade Estadual Paulista, Botucatu (SP), Brazil
Este item recebeu

Under a Creative Commons license
Informação do artigo
Resume
Texto Completo
Bibliografia
Baixar PDF
Estatísticas
Figuras (4)
Mostrar maisMostrar menos
Abstract

Molecular studies have shown more than one species of the genus Paracoccidioides to be the causal agent of paracoccidioidomycosis. Efforts have been made to correlate the identified species with epidemiological and clinical data of patients, aiming to determine the real meaning and impact of new species. Bearing this objective in mind, the authors report a clinical case of paracoccidioidomycosis, from São Paulo state, Brazil, that manifested as uncommon sarcoid-like cutaneous lesions and was caused by Paracoccidioides brasiliensis sensu stricto (S1a). The patient was treated with itraconazole 200mg/day for 12 months, with complete clinical remission.

Keywords:
Paracoccidioidomycosis
Sarcoidosis
Skin diseases
Skin manifestations
Texto Completo

Paracoccidioidomycosis (PCM) is a systemic mycosis caused by thermally dimorphic fungi of the genus Paracoccidioides. Recently, molecular studies have shown that P. brasiliensis (S1a, S1b) and related species P. americana (S2), P. restrepiensis (S3), P. venezuelensis (S4) and P. lutzii are possible etiological agents.1 Airborne infections occur mainly in rural areas, and the primary complex develops in the lungs.2 Clinical manifestation in adult patients typically includes oral, cutaneous and pulmonary involvement. Cutaneous lesions are reported to occur in 30% to 61.2% of studied patients.3 Most frequently, skin lesions result from hematogenous spread of fungi. The most common forms of lesion are ulcerative and ulcerous-vegetative, reported in up to 42.8% of cases in one series.3 Conversely, an infiltrative pattern similar to the plaque-type lesion of cutaneous sarcoidosis is very uncommon.4 The authors report a male patient with an unusual and extensive cutaneous involvement of a sarcoid-like skin lesion caused by P. brasiliensis sensu stricto (S1a).5

A 53-year-old male patient, from a rural area in the municipality of São Manuel (SP), was referred for evaluation of a facial skin lesion that had evolved over one year. Fever, weight loss, pulmonary complaints and comorbidities were denied, as was alcohol and tobacco use. On examination, we observed an infiltrative sarcoid-like skin lesion on the face (Figures 1 and 2). With the hypothesis of B-cell lymphoma or PCM, the lesion was submitted to a punch biopsy. The histopathology revealed a dense, granulomatous inflammatory dermal infiltrate of histiocytes and multinucleated giant cells with rare fungal cells, viewed in greater specificity with silver staining (Figures 3 and 4). Culture from a biopsy fragment incubated on Mycosel® at 35°C showed yeast cells diagnostic of Paracoccidioides genus. The isolate was molecularly characterized as P. brasiliensis sensu stricto (S1a) by sequencing ITS rDNA and gp43 exon 2 loci.5 PCR-RFLP (Restriction Fragment Length Polymorphism) of tub1 gene was also carried out to enable differentiation among Paracoccidioides spp.5,6 A thin-slice computed tomography of the thorax and abdomen showed no abnormalities. Laboratory data were within normal limits, with exception of ESR of 20 mm/h. Antibody screens for HIV, HBV, HCV and Paracoccidioides spp. (IDD) tested negative. Itraconazole 200 mg/day was used for 12 months, with complete clinical remission.

Figure 1.

Paracoccidioidomycosis: erythematoviolaceous, infiltrated, sarcoidosis--like lesions on the face

(0.08MB).
Figure 2.

Paracoccidioidomycosis: detail of infiltrated lesion and shallow ulcer

(0.11MB).
Figure 3.

Paracoccidioidomycosis: well-formed epithelioid granuloma with giant cell and no visible fungus. Hematoxylin & eosin, x100

(0.17MB).
Figure 4.

Paracoccidioidomycosis: isolated fungus cell with discrete multiple sporulation amid epithelioid granuloma. Grocott-Gomori, x100

(0.13MB).

In PCM, sarcoid-like lesion is an expression of equilibrium between infectious agent and host defense. The histological presentation comprises a well-developed epithelioid granuloma and multinucleated giant cells with scarce fungal elements, posing a diagnostic challenge even when using specific stain.7 In such circumstances, cases can be clinically and histologically misinterpreted as leprosy or another infectious disease, or even as non-infectious granulomatous dermatosis.7 Another unusual aspect of this case was the apparent absence of pulmonary involvement, which is the rule in adult male individuals. Itraconazole has been effective in PCM, as observed in this patient.8 Efforts have been made in every case, using molecular tools, to identify the correct species of genus Paracoccidioides and to correlate it with geographical origin, clinical aspects and response to treatment, to determine the real meaning and impact of the new species.9

Financial support: None.

Conflict of interest: None.

References
[1.]
Turissini DA, Gomez OM, Teixeira MM, McEwen JG, Matute DR.
Species boundaries in the human pathogen Paracoccidioides.
Fungal Genet Biol, 106 (2017), pp. 9-25
[2.]
Marques SA.
Paracoccidioidomycosis: epidemiological, clinical, diagnostic and treatment up dating.
An Bras Dermatol, 88 (2013), pp. 700-711
[3.]
Marques SA, Cortez DB, Lastoria JC, Camargo RMP, Marques MEA.
Paracoccidioidomycosis: frequency, morphology, and pathogenesis of tegumentary lesions.
An Bras Dermatol, 82 (2007), pp. 411-417
[4.]
Abreu MAMM, Lastória JC, Mattos ALA, Alchorne MMA.
Paracoccidioiodomycosis with sarcoid-like lesions: a diagnostic challenge.
Rev Soc Bras Med Trop, 50 (2017), pp. 273-276
[5.]
Hrycyk MF, Garcia Garces H, Bosco SMG, de Oliveira SL, Marques SA, Bagagli E.
Ecology of Paracoccidioides brasiliensis, P. lutzii and related species: infection in armadillos, soil occurrence and mycological aspects.
Med Mycol, (2018),
[6.]
Roberto TN, Rodrigues AM, Hahn RC, de Camargo ZP.
Identifying Paracoccidioides phylogenetic species by PCR-RFLP of the alpha-tubulin gene.
Med Mycol, 54 (2016), pp. 240-247
[7.]
Marques SA, Lastória JC, Putinatti MSMA, Camargo RMP, Marques MEA.
Paracoccidioidomycosis: infiltrated, sarcoid-like cutaneous lesions misinterpreted as tuberculoid leprosy.
Rev Inst Med Trop São Paulo, 50 (2008), pp. 47-50
[8.]
Shikanai-Yasuda MA, Mendes RP, Colombo AL, Queiroz-Telles F, Kono ASG, Paniago AMM, et al.
Brazilian guidelines for the clinical management of paracoccidioidomycosis.
Rev Soc Bras Med Trop, 50 (2017), pp. 715-740
[9.]
Munõz JF, Farrer RA, Desjardins CA, Gallo JE, Sykes S, Sakthikumar S, et al.
Genome Diversity, Recombination, and Virulence across the Major Lineages of Paracoccidioides.
mSphere, 1 (2016), pp. e00213-e00216

Work conducted at the Department of Dermatology and Radiotherapy, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista, Botucatu (SP), Brazil.

Copyright © 2018. Anais Brasileiros de Dermatologia
Baixar PDF
Idiomas
Anais Brasileiros de Dermatologia (Portuguese)
Opções de artigo
Ferramentas
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.